Controlling Blood Sugar May Help Prevent Dementia in People with Type 2 Diabetes
A groundbreaking study has found a significant link between blood sugar control and the risk of dementia in people with Type 2 diabetes. The research, which analyzed data from 350,000 individuals with Type 2 diabetes, revealed that those with poor blood sugar control were 50% more likely to be hospitalized with dementia than those with good control. The study's findings suggest that maintaining tight control of blood sugar levels may be a crucial factor in preventing dementia, which affects millions of people worldwide.
Key Takeaways:
- The study, presented at the European Association for the Study of Diabetes conference in Stockholm, analyzed data from 350,000 patients with Type 2 diabetes, making it one of the largest studies to examine the link between blood sugar control and dementia.
- Researchers found that people with high blood sugar levels, as measured by the HbA1c diabetic blood test, were 50% more likely to be hospitalized with dementia than those with good control.
- The study specifically looked at patients with Type 2 diabetes, who make up 90% of all diabetes cases in the UK.
- Poor blood sugar control was associated with hospital admissions for dementia, with 11,035 patients admitted with dementia or diagnosed with dementia alongside other illnesses.
- The research suggests that maintaining tight control of blood sugar levels may be a crucial factor in preventing dementia.
- Dr. Aidin Rawshani and colleagues suggest that improved blood sugar control may be a potential means of preventing dementia in people with Type 2 diabetes.
Statistics:
- 3.3 million people are diagnosed with diabetes in the UK, of which 90% have Type 2 diabetes.
- 11,035 patients (3.2%) were admitted to hospital with a main diagnosis of dementia or had dementia diagnosed alongside other illnesses.
- 350,000 patients with Type 2 diabetes were analyzed in the study, making it a significant sample size for research on this topic.
- The study was conducted from January 2004 to December 2012, with patients followed up until hospital admission for dementia, death, or the end of the study period.
Sources:
- European Association for the Study of Diabetes conference in Stockholm
- Swedish National Diabetes Registry
- Dr. Aidin Rawshani and colleagues' research
- Diabetes UK
- The Guardian (online article, no exact publication date mentioned)